ArticleScientific reports2025
A novel ST-GCN model based on homologous microstate for subject-independent seizure prediction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence-based biomarkers for the diagnosis and treatment of neurological conditions: a narrative review.Molecular brain · 2026Review
- Unsupervised clustering of pre-ictal EEG in children: a reproducible and lightweight CPU-based workflow.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Due to the lack of validated universal seizure markers, population-level prediction methods often exhibit limited performance. This study proposes homologous microstate dynamic attributes as a generalized, subject-independent seizure marker. Homologous microstate dynamic attributes were extracted using a novel spatiotemporal graph convolutional network (ST-GCN) model for subject-independent seizure prediction. An online deployment stage was introduced to validate the model's clinical applicability. The online deployment stage demonstrated that the model achieved sensitivities of 96.79% and 98.84% on the private dataset and Siena dataset, respectively. The ST-GCN model successfully predicts seizures in a subject-independent manner, demonstrating its potential as a generalized tool for seizure prediction in clinical settings. This study indicates that dynamics within homologous microstates can serve as a universal predictive biomarker for seizures, expanding microstate research beyond transition patterns. It also provides a practical template for clinical seizure prediction models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.